Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Ensem Therapeutics
Ensem Therapeutics
Atavistik Bio, Inc
Eli Lilly and Company
Intuitive Surgical
Stemline Therapeutics, Inc.
AstraZeneca
Perspectum
AstraZeneca
Incepta Pharmaceuticals Ltd